Expert on biopharmaceutical industry, MIT Sc.D.

Specialties & Experience of this Expert Witness

Additional Information

Management consultant and fractional management services to biopharma companies providing a broad set of services. Hands on management experience from Big Pharma, biotech companies, and as consultant COO for biotech companies. Consulting experience from Boston Consulting Group. Large industry network. Over 25 years broad experience in US, EU, Japan and Australia. Doctor of Science from MIT in Biochemical Engineering with minor in Management. Master of Science in Chemical Engineering from Royal Institute of Technology, Sweden. Consulting Experience from Boston Consulting Group, Arthur D. Little and IBM. Biopharma experience from Pharmacia, BASF Pharma and several biotech companies. Fulbright scholar. Member of the Umbrex, BiotechExcec and Alacrita consultant networks. Uniquely broad and deep experience both as a hands-on manager and consultant, in drug discovery, preclinical and clinical development (including IND filings and clinical trial management), biologics and gene therapy manufacturing, analytics and diagnostics, business and corporate development (large licensing and M&A deals), strategic planning (up to division level), portfolio management, product and therapeutic area strategies, major new product launches and commercial development planning, startup management and financing, University Technology Transfer. Experienced negotiator including large business development deals and vendor management. As consultant, retained as personal advisor to large pharmaceutical company CEO and as acting COO for several biotech companies. Academic teaching at graduate level (MIT). Experience from most therapeutic modalities, including small molecules, peptides, biologics (especially monoclonal antibodies), gene and cell therapies (especially AAV) and RNA therapeutics. Experience in most therapeutic areas, including obesity, oncology, gastrointestinal (functional and IBD), infectious disease (including HCV and HBV), CNS & pain, ophthalmology, immunology including allergy & RA, cardiovascular and respiratory (including asthma). Experience managing biologics and gene therapy manufacturing, including AAV vectors. Recent experience in GLP-1, GIP, PYY, amylin and glucagon receptor agents for obesity and diabetes. Experience with Artificial Intelligence and Machine Learning for drug discovery. Have managed 3 biotech companies as consultant COO/CEO. Have supported fundraising efforts in seed, series A and B, and Nasdaq listings and PIPEs. US and Swedish citizenship. Countries worked in: USA, Sweden, UK, France, Germany, Australia